Naval Daver, Deborah Thomas, Farhad Ravandi, Jorge Cortes, Rebecca Garris, Elias Jabbour, Guillermo Garcia-Manero, Gautam Borthakur, Tapan Kadia, Michael Rytting, Marina Konopleva, Hagop Kantarjian, and Susan O’Brien. 2015. “Final Report of a Phase II Study of Imatinib Mesylate With Hyper-CVAD for the Front-Line Treatment of Adult Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia”. Haematologica 100 (5). Pavia, Italy, 653-61. https://doi.org/10.3324/haematol.2014.118588.